1.46MMarket Cap-0.04P/E (TTM)
0.4812High0.4397Low385.49KVolume0.4600Open0.4723Pre Close177.29KTurnover13.44%Turnover Ratio0.00P/E (Static)3.31MShares29.000052wk High0.98P/B1.26MFloat Cap0.439752wk Low--Dividend TTM2.87MShs Float4647888000.0000Historical High--Div YieldTTM8.79%Amplitude0.4397Historical Low0.4590Avg Price1Lot Size
ReShape Lifesciences Stock Forum
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Monday, 10th March at 8:31 am
IRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent applica...
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
On watch
52 week low, all time low. Social sentiment picking up here. I don't know shit about the company but will monitor for confirmation of an uptrend and could be a possible day trade.
Can ReShape's New Canadian Partnership Transform Its Weight Loss Device Sales?
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
Tuesday, 25th February at 8:31 am
IRVINE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has signed a distribution agreement with Liaison Medical for distribution of ReShape's next generation, enhanced L...
No comment yet